Skip to content

Apotheek Geusens

Active Private limited companyfounded 2008active for 17 yearsDorpsstraat 61, 3900 PeltKBO/BCE: BE 0808.370.977 subsidiary of

Lifetime

16 annual accounts with figures on one time axis
peak of €567,348 in 2010
€255,420▼ 9.4%
peak of €130,035 in 2010
€89,629▼ 4.2%
peak of €400,445 in 2020
€215,168▼ 4.6%
€189,668▲ 0.1%
peak of 3.5 FTE in 2021
3.2 FTE▼ 8.6%
Board1 name since 2015
1 director
Owners
100%
Documentsfilings and deeds
26-11-202566 days before the deadline
2025abbreviated format
Staff from 3.5 FTE to 3.2 FTE1 director appointed, 1 resignation 30-12Dividend €100,000

Key points

from the 2025 annual accounts

Equity

€215,168 ▼ 4.6%
225,5392024+89,629Profit-100,000Dividend215,1682025

Apotheek Geusens paid out €100,000 in dividends. That is 112% of the 2025 profit.

Filings

16 annual accounts since 2010
deadline2010201520202025

The last five annual accounts were filed 39 to 69 days before the end of the period.

Board

1 left

1 director left, the latest on 30-12-2025. 1 is in office now.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,733 companies had the same profile as Apotheek Geusens has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,733 companies, not a prediction for Apotheek Geusens. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 13-11-2023
  • 100%score equity €811,876 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

1 director appointed, 1 resignation resigns · appointed · acts as permanent representative · General meeting of 21-11-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0808370977
appointed as director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 13-11-2023 · Gazette deed
1 manager appointed, 2 resignations (manager) and (manager) resign · appointed as manager · Discharge granted to · General meeting of 31-12-2014 · Gazette deed
All 25 events

Comparable companies

same main activity, similar in size and age
Company
Apotheek Geusens Pelt €404,835 €255,420 53.1% 3.2
PHARMACIE YSABEL DEMARET Charleroi €389,105 €227,700 24.0% 3.7
PHARMACIE STIBBE Ganshoren €360,528 €292,317 54.8% 3.3
APOTHEEK THIELEN Sint-Gillis-Waas €470,532 €307,570 67.1% 3.1
PHARMACIE SAINTE-WALBURGE Soumagne €362,400 €240,091 -5.3% 3.4
PHARMACIE VANNESTE Molenbeek-Saint-Jean €354,066 €229,255 39.2% 2.7
delta SUD PHARMA Virton €477,640 €208,418 30.0% 3.2

These companies have the same main activity as Apotheek Geusens: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €354,000 and €478,000, founded between 2005 and 2010.

Official details

Source: KBO
Status
Active since 11-12-2008Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 3 others
Joint committee
313Pharmacies and pricing offices · annual accounts 30-06-2023
Establishment unit
2.175.137.6013900 Pelt, since 05-01-2009
Financial year end
30 June
Peppol
Reachable since 26-07-2024
Company details

Annual accounts to 30-06-2025

≈ €880,000estimated
€404,835▼ 2.4%
Employeeson 30-06-2025
6▲ 20.0%
Filing
Filed on 26-11-2025, 66 days before the end of the filing period
Financials

Insights on Apotheek Geusens

Apotheek Geusens files the abbreviated format. That format states no turnover. The gross margin fell from €567,348 in 2010 to €255,420 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Apotheek Geusens

What is the company number of Apotheek Geusens?
The company number of Apotheek Geusens is 0808.370.977. The VAT number is the same number with BE in front: BE 0808.370.977.
Where is Apotheek Geusens based?
The registered office is at Dorpsstraat 61, 3900 Pelt.Company details
What does Apotheek Geusens do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Geusens?
Apotheek Geusens is a private limited company (BV).
When was Apotheek Geusens founded?
Apotheek Geusens was founded on 11-12-2008.
Is Apotheek Geusens still active?
Yes, Apotheek Geusens is an active enterprise in the KBO register.
How many employees does Apotheek Geusens have?
Apotheek Geusens had an average of 3.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Apotheek Geusens fall under?
In its 30-06-2023 annual accounts, Apotheek Geusens states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Apotheek Geusens?
The turnover in financial year 2025 is about €880,000. This figure is estimated from the gross margin of €255,420 and 42 comparable companies (NACE 477). It probably lies between €690,000 and €1.2m.
Is Apotheek Geusens profitable?
In financial year 2025, Apotheek Geusens made a profit of €89,629.
Where can I find the annual accounts of Apotheek Geusens?
Apotheek Geusens filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Geusens due?
Apotheek Geusens must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.